Supplementary tables and figures for the paper titled "Comparative efficacy of biologics and oral agents in palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network meta-analysis of randomized clinical trials".THIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE. TO VIEW A LIST OF FILES AND ACCESS THE FILES IN THIS DATASET CLICK ON THE DOI-LINK ABOV
Supplemental material, Online supplementary file 1, for Risk of Developing Melanoma With Systemic Ag...
BACKGROUND: This reviews goals were to investigate apremilasts efficacy versus placebo in palmoplant...
Contains fulltext : 176491.pdf (publisher's version ) (Open Access)Radboud Univers...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Supplemental material, Table S1, for Palmoplantar Pustulosis: Clinical Characteristics and Variabili...
Supplemental Material, Supplementary_Material_revised_Oct.10 for Guselkumab for the Treatment of Mod...
Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase IIb, Randomized Clinical Tria...
Supplemental material, Supplementary Material 1, for Elderly Onset Generalized Pustular Psoriasis: A...
Supplemental material for the manuscript, "Comparative Safety and Benefit-Risk Profile of Biologics ...
• Appendix 1: Search Strategy o eTable 1: Database(s): Ovid MEDLINE(R) Epub Ahead of Print, In-Proc...
<i>Background:</i> Biologics are a safe and efficacious therapy for psoriasis. The drug survival of ...
<b><i>Background:</i></b> Clinical studies of continuous versus intermittent biologic therapy for mo...
Supplemental Material, PRISMA_NMA_Checklist for Guselkumab for the Treatment of Moderate-to-Severe P...
<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...
Supplementary_File_1 for Circulating Levels of Osteopontin in Patients With Psoriasis: A Systematic ...
Supplemental material, Online supplementary file 1, for Risk of Developing Melanoma With Systemic Ag...
BACKGROUND: This reviews goals were to investigate apremilasts efficacy versus placebo in palmoplant...
Contains fulltext : 176491.pdf (publisher's version ) (Open Access)Radboud Univers...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Supplemental material, Table S1, for Palmoplantar Pustulosis: Clinical Characteristics and Variabili...
Supplemental Material, Supplementary_Material_revised_Oct.10 for Guselkumab for the Treatment of Mod...
Mendeley Supplemental Tables and Figures for Stein Gold et al. A Phase IIb, Randomized Clinical Tria...
Supplemental material, Supplementary Material 1, for Elderly Onset Generalized Pustular Psoriasis: A...
Supplemental material for the manuscript, "Comparative Safety and Benefit-Risk Profile of Biologics ...
• Appendix 1: Search Strategy o eTable 1: Database(s): Ovid MEDLINE(R) Epub Ahead of Print, In-Proc...
<i>Background:</i> Biologics are a safe and efficacious therapy for psoriasis. The drug survival of ...
<b><i>Background:</i></b> Clinical studies of continuous versus intermittent biologic therapy for mo...
Supplemental Material, PRISMA_NMA_Checklist for Guselkumab for the Treatment of Moderate-to-Severe P...
<p>Supplemental material, Table S1 for Quantitative evaluation to efficacy and safety of therapies f...
Supplementary_File_1 for Circulating Levels of Osteopontin in Patients With Psoriasis: A Systematic ...
Supplemental material, Online supplementary file 1, for Risk of Developing Melanoma With Systemic Ag...
BACKGROUND: This reviews goals were to investigate apremilasts efficacy versus placebo in palmoplant...
Contains fulltext : 176491.pdf (publisher's version ) (Open Access)Radboud Univers...